Page last updated: 2024-09-04

phosphorodithioic acid and Malignant Melanoma

phosphorodithioic acid has been researched along with Malignant Melanoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ager, CR; Curran, MA; Di Francesco, ME; Jones, P; Wei, Z; Zhang, H1
Amartey, J; Noe, CR; Stessl, M; Winkler, J1
Apfel, R; Bogdahn, U; Bosserhoff, AK; Fabel, K; Hau, P; Jachimczak, P; Schlingensiepen, KH; Schuler-Thurner, B; Tschertner, I; Wise, P1
Benimetskaya, L; Colombini, M; Lai, JC; Miller, P; Stein, CA; Tan, W1

Other Studies

4 other study(ies) available for phosphorodithioic acid and Malignant Melanoma

ArticleYear
Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy.
    Bioorganic & medicinal chemistry letters, 2019, 10-15, Volume: 29, Issue:20

    Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Line; Cytosol; Heterocyclic Compounds; Humans; Immunity, Innate; Immunotherapy; Interferon-beta; Melanoma; Melanoma, Experimental; Membrane Proteins; Mice; Nucleotides, Cyclic; Phosphates; Signal Transduction; Tumor Microenvironment

2019
Off-target effects related to the phosphorothioate modification of nucleic acids.
    ChemMedChem, 2010, Aug-02, Volume: 5, Issue:8

    Topics: Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Humans; Intercellular Adhesion Molecule-1; Lactates; Melanoma; Oligonucleotides, Antisense; Phosphates; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Thionucleotides

2010
Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques.
    International journal of cancer, 2005, Jan-01, Volume: 113, Issue:1

    Topics: Cell Line, Tumor; Cytotoxicity, Immunologic; Extracellular Matrix Proteins; Gene Expression Regulation, Neoplastic; Glioma; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukocytes, Mononuclear; Lymphocyte Activation; Melanoma; Neoplasm Proteins; Oligonucleotides, Antisense; Phosphates; Proteins; Recombinant Proteins; Thionucleotides

2005
A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, May-09, Volume: 103, Issue:19

    Topics: Base Sequence; Cell Line, Tumor; Cytochromes c; Humans; Ion Channel Gating; Melanoma; Mitochondria; Mitochondrial Membranes; Oligonucleotides; Phosphates; Thionucleotides; Voltage-Dependent Anion Channels

2006